Table of contents

Therapeutics

• Review: atypical antipsychotics and psychosocial interventions, alone or in combination, may reduce youth aggression (31 July, 2003) Free
• Review: it is unclear whether treating internalising disorders in childhood prevents substance abuse in adolescence (31 July, 2003) Free
• Review: parent training and community-based interventions may benefit children with disruptive behaviour disorders (31 July, 2003) Free
• Problem solving programme implemented by teachers may prevent depression in the short term, but longer term benefits are unclear (31 July, 2003) Free
• Review: electroconvulsive therapy may be an effective short term treatment for people with depression (31 July, 2003) Free
• Review: continuing antidepressants for 12 months following acute treatment may reduce the risk of relapse in depression (31 July, 2003) Free
• Adjunctive cognitive therapy is more effective, but more costly, than standard clinical management for relapse prevention in depression (31 July, 2003) Free
• Collaborative care may improve depression management in older adults (31 July, 2003) Free
• Review: counselling in primary care may have short term benefits for people with common mental disorders (31 July, 2003) Free
• Advance directives about treatment preferences had little impact on compulsory readmissions for people with serious mental illness (31 July, 2003) Free
• Review: women with schizophrenia have poorer pregnancy outcomes than other women, but it is unclear whether antipsychotic medications affect their infants (31 July, 2003) Free
• The benefits of exposure therapy alone may last longer than sertraline alone or sertraline plus exposure therapy in social phobia (31 July, 2003) Free
• Hydroxyzine may be safe and effective in generalised anxiety disorder (31 July, 2003) Free
• Buprenorphine may be more effective than clonidine and other symptomatic medications for short term ambulatory heroin withdrawal (31 July, 2003) Free
• Clozapine may be more effective than olanzapine for reducing suicidal behaviour in people with schizophrenia at high risk (31 July, 2003) Free
• Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer’s disease (31 July, 2003) Free